NYSE:IMV - IMV News Headlines

Sign in or create an account to add this stock to your watchlist.
$4.07 -0.04 (-0.97 %)
(As of 03/19/2019 11:27 AM ET)
Previous Close$4.11
Today's Range$4.07 - $4.23
52-Week Range$4.00 - $7.21
Volume700 shs
Average Volume29,046 shs
Market Capitalization$205.92 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

IMV (NYSE IMV) News Headlines

Source:
DateHeadline
-$0.07 Earnings Per Share Expected for Imv Inc (IMV) This Quarter-$0.07 Earnings Per Share Expected for Imv Inc (IMV) This Quarter
www.americanbankingnews.com - March 18 at 8:11 AM
IMV (IMV) Scheduled to Post Earnings on FridayIMV (IMV) Scheduled to Post Earnings on Friday
www.americanbankingnews.com - March 15 at 1:06 AM
IMV Researchers to Present New Preclinical Data at AACR Annual Meeting 2019IMV Researchers to Present New Preclinical Data at AACR Annual Meeting 2019
finance.yahoo.com - March 12 at 11:55 AM
IMV Inc. to Announce 2018 Fourth Quarter and Fiscal Year-End Results and Host Investor Conference Call and Webcast on March 22, 2019IMV Inc. to Announce 2018 Fourth Quarter and Fiscal Year-End Results and Host Investor Conference Call and Webcast on March 22, 2019
finance.yahoo.com - March 8 at 11:31 AM
IMV Inc. to Present at the Cowen and Company 39th Annual Health Care ConferenceIMV Inc. to Present at the Cowen and Company 39th Annual Health Care Conference
finance.yahoo.com - March 7 at 11:19 AM
Imv Inc (IMV) to Post FY2018 Earnings of ($0.31) Per Share, National Bank Financial ForecastsImv Inc (IMV) to Post FY2018 Earnings of ($0.31) Per Share, National Bank Financial Forecasts
www.americanbankingnews.com - March 7 at 6:47 AM
IMV Inc. Closes Previously Announced Public OfferingIMV Inc. Closes Previously Announced Public Offering
finance.yahoo.com - March 6 at 11:16 AM
IMV IncIMV Inc
www.bloomberg.com - March 5 at 8:10 AM
IMV prices 4.9M equity offeringIMV prices 4.9M equity offering
seekingalpha.com - March 1 at 11:35 AM
IMV Inc. Files Preliminary Prospectus Supplement for Proposed Public Offering of Common SharesIMV Inc. Files Preliminary Prospectus Supplement for Proposed Public Offering of Common Shares
finance.yahoo.com - March 1 at 11:35 AM
IMV Inc. Announces Pricing of Public OfferingIMV Inc. Announces Pricing of Public Offering
finance.yahoo.com - March 1 at 11:35 AM
 Analysts Expect Imv Inc (IMV) Will Announce Earnings of -$0.07 Per Share Analysts Expect Imv Inc (IMV) Will Announce Earnings of -$0.07 Per Share
www.americanbankingnews.com - February 23 at 5:18 PM
Should You Be Concerned About IMV Inc.’s (TSE:IMV) Historical Volatility?Should You Be Concerned About IMV Inc.’s (TSE:IMV) Historical Volatility?
finance.yahoo.com - February 22 at 3:39 PM
Mid-stage study of IMVs DPX-Survivac in ovarian cancer underwayMid-stage study of IMV's DPX-Survivac in ovarian cancer underway
seekingalpha.com - January 29 at 10:29 AM
IMV to Present at 2019 BIO CEO & Investor ConferenceIMV to Present at 2019 BIO CEO & Investor Conference
finance.yahoo.com - January 29 at 10:29 AM
IMV Announces Clinical Update for DPX-Survivac Program in Ovarian Cancer Following Positive Feedback from U.S. FDAIMV Announces Clinical Update for DPX-Survivac Program in Ovarian Cancer Following Positive Feedback from U.S. FDA
finance.yahoo.com - January 29 at 10:29 AM
Dosing underway in early-stage study of IMVs neoepitopesDosing underway in early-stage study of IMV's neoepitopes
seekingalpha.com - January 17 at 10:31 AM
First Patient Dosed in Phase 1 Clinical Trial Evaluating Neoepitopes Formulated in IMV’s DPX Delivery Platform in Ovarian Cancer PatientsFirst Patient Dosed in Phase 1 Clinical Trial Evaluating Neoepitopes Formulated in IMV’s DPX Delivery Platform in Ovarian Cancer Patients
finance.yahoo.com - January 17 at 10:31 AM
IMV Announces Updated Clinical Data Presentation for Lead Candidate DPX-Survivac’s Phase 1b/2 Immunotherapy Combination Trial at the ESMO Immuno-Oncology Congress 2018IMV Announces Updated Clinical Data Presentation for Lead Candidate DPX-Survivac’s Phase 1b/2 Immunotherapy Combination Trial at the ESMO Immuno-Oncology Congress 2018
finance.yahoo.com - December 10 at 8:19 AM
IMV Welcomes Marc Jasmin as Senior Director, Investor Relations and CommunicationsIMV Welcomes Marc Jasmin as Senior Director, Investor Relations and Communications
finance.yahoo.com - December 5 at 7:46 AM
IMV (IMV) Presents At Piper Jaffray 30th Annual Healthcare Conference - SlideshowIMV (IMV) Presents At Piper Jaffray 30th Annual Healthcare Conference - Slideshow
seekingalpha.com - November 28 at 3:21 PM
IMV Leadership to Present Respiratory Syncytial Virus (RSV) Research at RespiDART 2018IMV Leadership to Present Respiratory Syncytial Virus (RSV) Research at RespiDART 2018
finance.yahoo.com - November 27 at 7:46 AM
IMV Moves to Develop DPX-Survivac as Monotherapy for Recurrent Ovarian CancerIMV Moves to Develop DPX-Survivac as Monotherapy for Recurrent Ovarian Cancer
finance.yahoo.com - November 20 at 7:22 AM
IMV (IMV) Presents At DAWSON JAMES 4th Annual Small Cap Growth Conference - SlideshowIMV (IMV) Presents At DAWSON JAMES 4th Annual Small Cap Growth Conference - Slideshow
seekingalpha.com - November 1 at 6:24 AM
This page was last updated on 3/19/2019 by MarketBeat.com Staff

Featured Article: The risks of owning bonds

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel